| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
56.72
|
|
2
|
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
50.94
|
|
3
|
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
41.47
|
|
4
|
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
26.95
|
|
5
|
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
|
Lancet
|
2015
|
7.99
|
|
6
|
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.
|
Lancet
|
2015
|
6.13
|
|
7
|
UK health performance: findings of the Global Burden of Disease Study 2010.
|
Lancet
|
2013
|
6.11
|
|
8
|
Heat effects on mortality in 15 European cities.
|
Epidemiology
|
2008
|
4.63
|
|
9
|
An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure.
|
Environ Health Perspect
|
2014
|
3.69
|
|
10
|
Public health benefits of strategies to reduce greenhouse-gas emissions: health implications of short-lived greenhouse pollutants.
|
Lancet
|
2009
|
3.22
|
|
11
|
Acute effects of ozone on mortality from the "air pollution and health: a European approach" project.
|
Am J Respir Crit Care Med
|
2004
|
2.89
|
|
12
|
High temperature and hospitalizations for cardiovascular and respiratory causes in 12 European cities.
|
Am J Respir Crit Care Med
|
2008
|
2.81
|
|
13
|
Is eczema really on the increase worldwide?
|
J Allergy Clin Immunol
|
2007
|
2.46
|
|
14
|
Air pollution and health: a European and North American approach (APHENA).
|
Res Rep Health Eff Inst
|
2009
|
2.33
|
|
15
|
Black carbon as an additional indicator of the adverse health effects of airborne particles compared with PM10 and PM2.5.
|
Environ Health Perspect
|
2011
|
2.08
|
|
16
|
Association between migraine and asthma: matched case-control study.
|
Br J Gen Pract
|
2002
|
1.76
|
|
17
|
Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data.
|
BMJ
|
2003
|
1.58
|
|
18
|
Mortality associations with long-term exposure to outdoor air pollution in a national English cohort.
|
Am J Respir Crit Care Med
|
2013
|
1.50
|
|
19
|
Long-term exposure to outdoor air pollution and incidence of cardiovascular diseases.
|
Epidemiology
|
2013
|
1.45
|
|
20
|
Outdoor air pollution and respiratory health in patients with COPD.
|
Thorax
|
2011
|
1.42
|
|
21
|
A tale of two cities: effects of air pollution on hospital admissions in Hong Kong and London compared.
|
Environ Health Perspect
|
2002
|
1.31
|
|
22
|
Ambient air pollution: a cause of COPD?
|
Eur Respir J
|
2013
|
1.24
|
|
23
|
Urban ambient particle metrics and health: a time-series analysis.
|
Epidemiology
|
2010
|
1.23
|
|
24
|
Self-reported truck traffic on the street of residence and symptoms of asthma and allergic disease: a global relationship in ISAAC phase 3.
|
Environ Health Perspect
|
2009
|
1.23
|
|
25
|
Quantifying the health impacts of ambient air pollutants: recommendations of a WHO/Europe project.
|
Int J Public Health
|
2015
|
1.11
|
|
26
|
Prevalence of asthma.
|
BMJ
|
2005
|
1.09
|
|
27
|
Does outdoor air pollution induce new cases of asthma? Biological plausibility and evidence; a review.
|
Respirology
|
2012
|
1.07
|
|
28
|
The impact of the congestion charging scheme on air quality in London. Part 1. Emissions modeling and analysis of air pollution measurements.
|
Res Rep Health Eff Inst
|
2011
|
0.96
|
|
29
|
Concentration-response function for ozone and daily mortality: results from five urban and five rural U.K. populations.
|
Environ Health Perspect
|
2012
|
0.92
|
|
30
|
Childhood chest illness and the rate of decline of adult lung function between ages 35 and 45 years.
|
Am J Respir Crit Care Med
|
2006
|
0.92
|
|
31
|
Acute effects of ambient ozone on mortality in Europe and North America: results from the APHENA study.
|
Air Qual Atmos Health
|
2013
|
0.90
|
|
32
|
The London low emission zone baseline study.
|
Res Rep Health Eff Inst
|
2011
|
0.87
|
|
33
|
Measurement and modeling of exposure to selected air toxics for health effects studies and verification by biomarkers.
|
Res Rep Health Eff Inst
|
2009
|
0.86
|
|
34
|
The impact of the congestion charging scheme on air quality in London. Part 2. Analysis of the oxidative potential of particulate matter.
|
Res Rep Health Eff Inst
|
2011
|
0.85
|
|
35
|
Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.
|
Res Rep Health Eff Inst
|
2012
|
0.76
|
|
36
|
Bronchodilator treatment and asthma death: a new analysis of a British case-control study.
|
Respir Med
|
2010
|
0.76
|
|
37
|
Twenty-five years of volatile substance abuse mortality: a national mortality surveillance programme.
|
Addiction
|
2012
|
0.76
|